Research Interests

  • Clinical trial design, conduct and analysis: Completion of phase I, II and III trials for patients with lymphoma, myeloma, leukemia and sarcoma.
  • Clinical trial methodology: Investigation of means to conduct trials more efficiently, while maintaining patient safety and privacy.
  • Under-represented populations: Enhancing research opportunities and clinical trial uptake for the elderly, and adolescents and young adults with cancer.
  • Economic analyses:  Determining the costs and benefits of an intervention, aiding policy makers.

Selected Publication: 

Hay AE, Klimm B, Chen BE, Goergen H, Shepherd LE, Fuchs M, Gospodarowicz MK, Borchmann P, Connors JM, Markova J, Crump M, Lohri A, Winter JN, Dörken B, Pearcey RG, Diehl V, Horning SJ, Eich HT, Engert A, Meyer RM. An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma. Conducted by the NCIC Clinical Trials Group (Canada) and German Hodgkin Study Group (GHSG). Ann Oncol. 2013 December 24(12):3065-9. doi: 10.1093/annonc/mdt389. Epub 2013 Oct 11.

More information on Dr. Hay's research can be found here: